Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Koole SN"'
Autor:
Aronson SL; Center for Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Walker C; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Graduate School for Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland., Thijssen B; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., van de Vijver KK; Center for Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology & Cancer Research Institute Ghent (CRIG), Ghent University Hospital, Ghent, Belgium., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Alkemade M; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Koole SN; Center for Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lopez-Yurda M; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lok CAR; Center for Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rottenberg S; Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.; Bern Center for Precision Medicine, University of Bern, Bern, Switzerland., van Rheenen J; Department of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Driel WJ; Center for Gynecologic Oncology Amsterdam, Department of Gynecologic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.v.driel@nki.nl., Kester LA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hahn K; Department of Molecular Pathology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Aug; Vol. 131 (3), pp. 565-576. Date of Electronic Publication: 2024 Jun 12.
Lessons learned from postmarketing withdrawals of expedited approvals for oncology drug indications.
Autor:
Koole SN; Medical Advisory Department, ONVZ Health Insurance, Houten, Netherlands. Electronic address: s.koole.res@gmail.com., Huisman AH; Zorgverzekeraars Nederland, Zeist, Netherlands., Timmers L; Care Department, National Health Care Institute, Diemen, Netherlands., Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, Netherlands., van Breugel E; Medical Advisory Department, VGZ Health Insurance, Arnhem, Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands., van Waalwijk van Doorn-Khosrovani SB; Medical Advisory Department, CZ Health Insurance, Tilburg, Netherlands; Department of Oncology, Leiden University Medical Centre, Leiden, Netherlands.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Mar; Vol. 25 (3), pp. e126-e135.
Autor:
Vancoppenolle JM; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department Health Technology and Services Research Technical Medical Centre, University of Twente, Enschede, The Netherlands.; The European Fair Pricing Network, Amsterdam, The Netherlands., Franzen N; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department Health Technology and Services Research Technical Medical Centre, University of Twente, Enschede, The Netherlands.; The European Fair Pricing Network, Amsterdam, The Netherlands., Koole SN; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands., Retèl VP; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Erasmus School of Health Policy & Management Health Technology Assessment (HTA), Erasmus University Rotterdam, The Netherlands., van Harten WH; Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Department Health Technology and Services Research Technical Medical Centre, University of Twente, Enschede, The Netherlands.; The European Fair Pricing Network, Amsterdam, The Netherlands.; Organization of European Cancer Institutes (OECI), Brussels, Belgium.
Publikováno v:
International journal of cancer [Int J Cancer] 2024 Mar 01; Vol. 154 (5), pp. 886-894. Date of Electronic Publication: 2023 Oct 20.
Autor:
Aronson SL; Department of Gynecologic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Lopez-Yurda M; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, Netherlands., Koole SN; Department of Gynecologic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Schagen van Leeuwen JH; Department of Obstetrics and Gynecology, Sint Antonius Hospital, Nieuwegein, Netherlands., Schreuder HWR; Department of Gynecologic Oncology, UMC Utrecht Cancer Center, Utrecht, Netherlands., Hermans RHM; Department of Gynecology and Obstetrics, Catharina Hospital, Eindhoven, Netherlands., de Hingh IHJT; Department of Surgery, Catharina Hospital, Eindhoven, Netherlands; Department of Epidemiology, GROW-School for Oncology Reproduction, Maastricht University, Maastricht, Netherlands., van Gent MDJM; Department of Obstetrics and Gynecology, Amsterdam University Medical Center, Amsterdam, Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, Netherlands., Arts HJG; Department of Gynecologic Oncology, University Medical Center Groningen, Groningen, Netherlands., van Ham MAPC; Department of Gynecologic Oncology, Radboud University Medical Centre, Nijmegen, Netherlands., van Dam PA; Department of Gynecologic Oncology, University Hospital Antwerp, Antwerp, Belgium., Vuylsteke P; Department of Medical Oncology, UCL Louvain, CHU Namur Sainte-Elisabeth, Namur, Belgium; Department of Internal Medicine, University of Botswana, Gaborone, Botswana., Aalbers AGJ; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., Verwaal VJ; Department of Surgery, Skåne University Hospital, Malmö, Sweden., Van de Vijver KK; Department of Pathology, Ghent University Hospital, Ghent, Belgium., Aaronson NK; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van Driel WJ; Department of Gynecologic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands; Center for Gynecologic Oncology Amsterdam, Amsterdam, Netherlands. Electronic address: w.v.driel@nki.nl.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2023 Oct; Vol. 24 (10), pp. 1109-1118. Date of Electronic Publication: 2023 Sep 11.
Autor:
Vancoppenolle JM; Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Koole SN; Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands., O'Mahony JF; Organization of European Cancer Institutes (OECI), Brussels B 1000, Belgium; Centre for Health Policy and Management, School of Medicine, Trinity College Dublin, Dublin, Ireland., Franzen N; Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Burgers JA; Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands., Retèl VP; Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands; Organization of European Cancer Institutes (OECI), Brussels B 1000, Belgium; Erasmus School of Health Policy & Management Health Technology Assessment (HTA), Erasmus University Rotterdam, The Netherlands., van Harten WH; Netherlands Cancer Institute-Antoni van Leeuwenhoek Amsterdam, The Netherlands; Health Technology and Services Research Department, Technical Medical Centre, University of Twente, Enschede, The Netherlands; Organization of European Cancer Institutes (OECI), Brussels B 1000, Belgium. Electronic address: w.v.harten@nki.nl.
Publikováno v:
Drug discovery today [Drug Discov Today] 2023 Aug; Vol. 28 (8), pp. 103620. Date of Electronic Publication: 2023 May 16.
Autor:
Koole SN; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Driel WJ; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2022 Dec 01; Vol. 151 (11), pp. 2057-2058. Date of Electronic Publication: 2022 Aug 05.
Autor:
Koole SN; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hauke J; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Nederlof P; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Richters LK; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Krebsbach G; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Sikorska K; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Alkemade M; Core Facility of Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Core Facility of Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schagen van Leeuwen JH; Department of Obstetrics & Gynecology, Sint Antonius Hospital, Nieuwegein, The Netherlands., Schreuder HWR; Department of Gynecological Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Hermans RHM; Department of Gynecology and Obstetrics, Catharina Hospital, Eindhoven, The Netherlands., de Hingh IHJT; Department of Surgical Oncology, Catharina Hospital, Eindhoven, The Netherlands., Mom CH; Department of Obstetrics and Gynecology, Amsterdam University Medical Center, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Arts HJG; Department of Gynecological Oncology, University Medical Center Groningen, Groningen, The Netherlands., van Ham M; Department of Gynecological Oncology, Radboud University Medical Center, Nijmegen, The Netherlands., van Dam P; Department of Gynecologic Oncology, University Hospital Antwerp, Antwerp, Belgium., Vuylsteke P; Department of Medical Oncology, UCL Louvain, CHU Namur Sainte-Elisabeth, Namur, Belgium.; University of Botswana, Gaborone, Botswana., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van de Vijver KK; Department of Pathology, University Hospital Ghent, Ghent, Belgium., Hahnen E; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., van Driel WJ; Department of Gynecology, The Netherlands Cancer Institute, Center of Gynecologic Oncology Amsterdam, Amsterdam, The Netherlands., Schmutzler R; Faculty of Medicine and Center for Familial Breast and Ovarian Cancer and Center for Integrated Oncology (CIO), Cologne, University Hospital Cologne, Cologne, Germany., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
International journal of cancer [Int J Cancer] 2022 Oct 15; Vol. 151 (8), pp. 1394-1404. Date of Electronic Publication: 2022 Jun 04.
Autor:
Koole SN; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Vessies DCL; Department of Laboratory Medicine, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Schuurbiers MMF; Department of Pulmonary Diseases, Radboud University Medical Centre, 6525 XZ Nijmegen, The Netherlands., Kramer A; Department of Epidemiology and Data Science, Amsterdam University Medical Centers (Location VUmc), 1081 HV Amsterdam, The Netherlands., Schouten RD; Department of Pulmonology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Degeling K; Cancer Health Services Research, Centre for Health Policy & Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne VIC 3010, Australia., Bosch LJW; Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., van den Heuvel MM; Department of Pulmonary Diseases, Radboud University Medical Centre, 6525 XZ Nijmegen, The Netherlands., van Harten WH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Department of Health Technology and Services Research University of Twente, 7522 NB Enschede, The Netherlands., van den Broek D; Department of Clinical Chemistry, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Retèl VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; Department of Health Technology and Services Research University of Twente, 7522 NB Enschede, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Mar 31; Vol. 14 (7). Date of Electronic Publication: 2022 Mar 31.
Autor:
Engbersen MP; Department of Radiology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, PO Box 900203, 1006, BE, Amsterdam, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., Lahaye MJ; Department of Radiology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, PO Box 900203, 1006, BE, Amsterdam, the Netherlands., Lok CAR; Center of Gynecological Oncology Amsterdam, Department of Gynecology, Antoni van Leeuwenhoek- Netherlands Cancer Institute, PO Box 900203, 1006, BE, Amsterdam, the Netherlands., Koole SN; Center of Gynecological Oncology Amsterdam, Department of Gynecology, Antoni van Leeuwenhoek- Netherlands Cancer Institute, PO Box 900203, 1006, BE, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, Antoni van Leeuwenhoek- Netherlands Cancer Institute, PO Box 900203, 1006, BE, Amsterdam, the Netherlands., Beets-Tan RGH; Department of Radiology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, PO Box 900203, 1006, BE, Amsterdam, the Netherlands; GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., Van Driel WJ; Center of Gynecological Oncology Amsterdam, Department of Gynecology, Antoni van Leeuwenhoek- Netherlands Cancer Institute, PO Box 900203, 1006, BE, Amsterdam, the Netherlands. Electronic address: w.v.driel@nki.nl.
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 Aug; Vol. 47 (8), pp. 1856-1861. Date of Electronic Publication: 2021 Mar 29.
Autor:
van de Wiel HJ; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Stuiver MM; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Center for Quality of Life, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Center of Expertise Urban Vitality, Faculty of Health, Amsterdam University of Applied Sciences, Tafelbergweg 51, 1105 BD Amsterdam, The Netherlands., May AM; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, P.O. Box 85500, 3508 GA Utrecht, The Netherlands., van Grinsven S; Rijnstate Hospital, Wagnerlaan 55, 6815 AD Arnhem, The Netherlands., Aaronson NK; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Oldenburg HSA; Division of Surgical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., van der Poel HG; Department of Urology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Koole SN; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Retèl VP; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Health Technology and Services research, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands., van Harten WH; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Rijnstate Hospital, Wagnerlaan 55, 6815 AD Arnhem, The Netherlands.; Department of Health Technology and Services research, University of Twente, Drienerlolaan 5, 7522 NB Enschede, The Netherlands., Groen WG; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2021 Jul 21; Vol. 13 (15). Date of Electronic Publication: 2021 Jul 21.